444 related articles for article (PubMed ID: 26881137)
1. Current Research Therapeutic Strategies for Alzheimer's Disease Treatment.
Folch J; Petrov D; Ettcheto M; Abad S; Sánchez-López E; García ML; Olloquequi J; Beas-Zarate C; Auladell C; Camins A
Neural Plast; 2016; 2016():8501693. PubMed ID: 26881137
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
Um JW; Kaufman AC; Kostylev M; Heiss JK; Stagi M; Takahashi H; Kerrisk ME; Vortmeyer A; Wisniewski T; Koleske AJ; Gunther EC; Nygaard HB; Strittmatter SM
Neuron; 2013 Sep; 79(5):887-902. PubMed ID: 24012003
[TBL] [Abstract][Full Text] [Related]
4. Targeting Fyn Kinase in Alzheimer's Disease.
Nygaard HB
Biol Psychiatry; 2018 Feb; 83(4):369-376. PubMed ID: 28709498
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
Um JW; Strittmatter SM
Prion; 2013; 7(1):37-41. PubMed ID: 22987042
[TBL] [Abstract][Full Text] [Related]
6. Cellular prion protein as a therapeutic target in Alzheimer's disease.
Laurén J
J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
[TBL] [Abstract][Full Text] [Related]
7. The Y
Matrone C; Iannuzzi F; Annunziato L
Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
9. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
[TBL] [Abstract][Full Text] [Related]
10. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease.
Haas LT; Strittmatter SM
J Biol Chem; 2016 Aug; 291(33):17112-21. PubMed ID: 27325698
[TBL] [Abstract][Full Text] [Related]
11. The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease.
Larson M; Sherman MA; Amar F; Nuvolone M; Schneider JA; Bennett DA; Aguzzi A; Lesné SE
J Neurosci; 2012 Nov; 32(47):16857-71a. PubMed ID: 23175838
[TBL] [Abstract][Full Text] [Related]
12. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
Smith LM; Kostylev MA; Lee S; Strittmatter SM
J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
[TBL] [Abstract][Full Text] [Related]
13. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.
Kaufman AC; Salazar SV; Haas LT; Yang J; Kostylev MA; Jeng AT; Robinson SA; Gunther EC; van Dyck CH; Nygaard HB; Strittmatter SM
Ann Neurol; 2015 Jun; 77(6):953-71. PubMed ID: 25707991
[TBL] [Abstract][Full Text] [Related]
14. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model.
Smith LM; Zhu R; Strittmatter SM
Neuropharmacology; 2018 Mar; 130():54-61. PubMed ID: 29191754
[TBL] [Abstract][Full Text] [Related]
15. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.
Ittner LM; Ke YD; Delerue F; Bi M; Gladbach A; van Eersel J; Wölfing H; Chieng BC; Christie MJ; Napier IA; Eckert A; Staufenbiel M; Hardeman E; Götz J
Cell; 2010 Aug; 142(3):387-97. PubMed ID: 20655099
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.
Chen RJ; Chang WW; Lin YC; Cheng PL; Chen YR
ACS Chem Neurosci; 2013 Sep; 4(9):1287-96. PubMed ID: 23805846
[TBL] [Abstract][Full Text] [Related]
17. Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients.
Iannuzzi F; Sirabella R; Canu N; Maier TJ; Annunziato L; Matrone C
Cells; 2020 Jul; 9(8):. PubMed ID: 32751526
[TBL] [Abstract][Full Text] [Related]
18. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
20. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
Bate C; Williams A
Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
